Eosinophils: Nemeses of Pulmonary Pathogens?
- 125 Downloads
Purpose of Review
Eosinophils are short-lived granulocytes that contain a variety of proteins and lipids traditionally associated with host defense against parasites. The primary goal of this review is to examine more recent evidence that challenged this rather outdated role of eosinophils in the context of pulmonary infections with helminths, viruses, and bacteria.
While eosinophil mechanisms that counter parasites, viruses, and bacteria are similar, the kinetics and impact may differ by pathogen type. Major antiparasitic responses include direct killing and immunoregulation, as well as some mechanisms by which parasite survival/growth is supported. Antiviral defenses may be as unembellished as granule protein-induced direct killing or more urbane as serving as a conduit for better adaptive immune responses to the invading virus. Although sacrificial, eosinophil DNA emitted in response to bacteria helps trap bacteria to limit dissemination. Herein, we discuss the current research redefining eosinophils as multifunctional cells that are active participants in host defense against lung pathogens.
Eosinophils recognize and differentially respond to invading pathogens, allowing them to deploy innate defense mechanisms to contain and clear the infection, or modulate the immune response. Modern technology and animal models have unraveled hitherto unknown capabilities of this surreptitious cell that indubitably has more functions awaiting discovery.
KeywordsHelminth Virus Bacteria
AES wishes to thank all those eosinophil aficionados (Drs. Helene Rosenberg, Praveen Akuthota, Rossana Melo, Hirohito Kita, Elizabeth Jacobsen, and especially the late Dr. James Lee) that have guided her viewpoint through conversation on all “things” eosinophil! We thank John Snyder for the artistic rendering of the eosinophil.
This work was supported in part by the National Institutes of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI125481 to AES.
Compliance with Ethical Standards
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Conflict of Interest
The authors declare no conflicts of interest relevant to this manuscript.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 2.McGarry MP. The evolutionary origins and presence of eosinophils in extant species. In: Rosenberg HF, Lee JJ, editors. Eosinophils in health and disease: Elsevier; 2013. p. 13–7.Google Scholar
- 3.• Lee JJ, et al. Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy. 2010;40(4):563–75 This article provides an in-depth argument for why eosinophils should not be inferred as terminally differentiated cells that are harmful to the host when activated, but instead, why they should be considered a component of the innate immune system that performs a more sophisticated role in maintaining tissue homeostasis aiding in healing and repair. PubMedPubMedCentralGoogle Scholar
- 19.Farne, H.A., et al., Anti-IL-5 therapies for asthma, in Cochrane Database Syst Rev. 2017;9:CD010834. https://doi.org/10.1002/14651858.CD010834.pub3.
- 24.Joseph D, Puttaswamy RK, Krovvidi H. Non-respiratory functions of the lung. Continuing Education in Anaesthesia Critical Care and Pain. 2013;13(3):98–102.Google Scholar
- 32.Gazzinelli-Guimaraes PH, Nutman TB. Helminth parasites and immune regulation. F1000Res. 2018 Oct 23;7. https://doi.org/10.12688/f1000research.15596.1.eCollection2018.
- 43.• Huang L, Appleton JA. Eosinophils in helminth infection: defenders and dupes. Trends Parasitol. 2016;32(10):798–807 This paper provides a balanced review of the role of eosinophils during worm infections focusing on both the beneficial and detrimental aspects to the parasite. PubMedPubMedCentralGoogle Scholar
- 49.•• Samarasinghe AE, Melo RCN, Duan S, LeMessurier KS, Liedmann S, Surman SL, et al. Eosinophils promote antiviral immunity in mice infected with influenza A virus. J Immunol. 2017;198(8):3214–26 This paper reports that eosinophils can be infected by influenza A virus, selectively release granule contents by piecemeal degranulation during influenza, and act as antigen-presenting cells to CD8 + T cells. PubMedPubMedCentralGoogle Scholar
- 50.•• Percopo CM, Dyer KD, Ochkur SI, Luo JL, Fischer ER, Lee JJ, et al. Activated mouse eosinophils protect against lethal respiratory virus infection. Blood. 2014;123(5):743–52 Here, the authors provide in vivo evidence that eosinophils can be activated by pneumonia virus infection of mice, resulting in degranulation and reduced viral load. PubMedPubMedCentralGoogle Scholar
- 61.• Samarasinghe AE, Woolard SN, Boyd KL, Hoselton SA, Schuh JM, McCullers JA. The immune profile associated with acute allergic asthma accelerates clearance of influenza virus. Immunol Cell Biol. 2014;92:449–59 This paper reports the unexpected observation that acute allergic asthma, which is associated with lung eosinophilia is a protective co-morbidity during influenza A infection with increased virus-specific CD8 + T cells. These in vivo data support a role for eosinophils in the anti-viral response. PubMedPubMedCentralGoogle Scholar
- 67.•• Domachowske JB, et al. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis. 1998;177(6):1458–64 This paper provides the first indication that eosinophil granule proteins have antiviral potential. PubMedGoogle Scholar
- 71.MacPherson JC, Comhair SAA, Erzurum SC, Klein DF, Lipscomb MF, Kavuru MS, et al. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol. 2001;166(9):5763–72.PubMedGoogle Scholar
- 85.•• Yousefi S, et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med. 2008;14(9):949–53 This paper provides evidence that eosinophils release mitochondrial DNA in defense against Gram-negative bacteria without compromising its viability. PubMedGoogle Scholar
- 88.• Ueki S, Melo RCN, Ghiran I, Spencer LA, Dvorak AM, Weller PF. Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood. 2013;121(11):2074–83 This paper provides evidence for extracellular trap formation by eosinophils when activated through immunoglobulins, PAF, calcium ionophore, and PMA in a process termed EETosis. PubMedPubMedCentralGoogle Scholar
- 94.•• Percopo CM, Krumholz JO, Fischer ER, Kraemer LS, Ma M, Laky K, et al. Impact of eosinophil-peroxidase (EPX) deficiency on eosinophil structure and function in mouse airways. J Leukoc Biol. 2019;105(1):151–61 This paper describes one of the few studies that translate in vitro bactericidal properties of eosinophil granule proteins to in vivo models. Despite reports that EPX is bactericidal in vitro, the authors found that mice lacking EPX were able to clear Haemophilus influenzae equally as well as EPX-sufficient mice. PubMedGoogle Scholar
- 102.Domachowske JB, Bonville CA, Dyer KD, Rosenberg HF. Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus. Nucleic Acids Res. 1998;26(23):5327–32.PubMedPubMedCentralGoogle Scholar
- 125.Wedi B, Wieczorek D, Stünkel T, Breuer K, Kapp A. Staphylococcal exotoxins exert proinflammatory effects through inhibition of eosinophil apoptosis, increased surface antigen expression (CD11b, CD45, CD54, and CD69), and enhanced cytokine-activated oxidative burst, thereby triggering allergic inflammatory reactions. J Allergy Clin Immunol. 2002;109(3):477–84.PubMedGoogle Scholar